Fill-Finish & Packaging

Image: iStock/EikoTsuttiy

Biocon's second fill/finish line at Bangalore site to come online later this year

Mylan and Biocon Neulasta biosimilar to go under US FDA scrutiny

By Dan Stanton

Biocon’s biomanufacturing facilities in India will need a “meaningful capacity expansion” to cope with long-term global biosimilar demand, the firm says.

Inside Celltrion: a biosimilar success story built on landfill

Dispatches from Korea

Inside Celltrion: a biosimilar success story built on landfill

By Dan Stanton

Ambition, hard work and a focus on quality has made Celltrion the ‘pioneers of the mAb biosimilar industry,’ the firm told Biopharma-Reporter during a tour of its biomanufacturing site in Songdo, Korea.